Title : Bempedoic Acid in the Treatment of Patients with Dyslipidemias and Statin Intolerance.

Pub. Date : 2021 Aug

PMID : 33502687






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Bempedoic acid (ETC-1002) is a new inhibitor of cholesterol synthesis that targets ATP citrate lyase (ACL). 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid ATP citrate lyase Homo sapiens
2 Bempedoic acid (ETC-1002) is a new inhibitor of cholesterol synthesis that targets ATP citrate lyase (ACL). 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid ATP citrate lyase Homo sapiens